Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438763 · ClinicalTrials.gov registry record
CMC Arthritis - Neoprene Vs. Thermoplast Short Opponens Splinting
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 120
- Enrollment target
NCT00438763: Completed study, sponsored by Massachusetts General Hospital.
NCT00438763 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438763 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Carpometacarpal Thumb Arthritis is a disease caused by different factors and attacks mainly woman older than 50 years. The signs and symptoms consist in pain, swelling, joint instability, deformity and loss of motion. Some evidence has shown that splinting of the thumb may be of benefit. There are two methods of splinting: The first is Standard Neoprene wrap-on thumb support (in which the finger is kept in the same position with in a standard Neoprene thumb splint). The second is Thermoplast Short Opponens splint (This splint is custom-made and the thumb is use as a template to design the splint). The purpose of this study is to test and evaluate these two protocols of splinting and assess which one helps or works better in patients with thumb arthritis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2005-12 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00438763
The ClinicalTrials.gov registry entry for NCT00438763 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00438763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00438763 about?
NCT00438763 is a clinical study titled "CMC Arthritis - Neoprene Vs. Thermoplast Short Opponens Splinting". Carpometacarpal Thumb Arthritis is a disease caused by different factors and attacks mainly woman older than 50 years. The signs and symptoms consist in pain, swelling, joint instability, deformity and loss of motion. Some evidence has shown that splinting of the thumb may be of benefit. There are t...
What is the current status of trial NCT00438763?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2005-12. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT00438763?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.